Clinical Trials on Glycogen Storage Disease Type 2 in South Africa
Total 4057 results
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II | Pompe Disease Infantile-OnsetUnited States, France, South Africa
-
University of PretoriaSouth African Sugar AssociationCompletedType 2 Diabetes MellitusSouth Africa
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Lannett Company, Inc.Parexel; FARMOVS (Pty) LtdCompletedType 2 Diabetes Mellitus | Type 1 Diabetes MellitusSouth Africa
-
Prosidion Ltd.Completed
-
BioMarin PharmaceuticalTerminatedPompe DiseaseUnited States, United Kingdom, Australia, France, Germany, New Zealand
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
Amicus TherapeuticsActive, not recruitingPompe DiseaseUnited States, Netherlands, United Kingdom, Australia, Germany, New Zealand
-
Amicus TherapeuticsRecruitingPompe Disease (Late-onset)United States, Taiwan, Japan, Australia, Canada
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
University of PretoriaNestlè Nutrition Institute Africa; South African Sugar AssociationCompletedDiabetes Mellitus, Type II [Non-insulin Dependent Type] [NIDDM Type] UncontrolledSouth Africa
-
Wits Health Consortium (Pty) LtdDiscovery VitalityActive, not recruitingType 2 Diabetes | Pre-diabetesSouth Africa
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Genzyme, a Sanofi CompanyRecruitingGlycogen Storage Disease Type II | Pompe DiseaseHungary, Croatia, Serbia, United States, Argentina, Australia, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Denmark, France, Germany, Greece, Hong Kong, India, Indonesia, Israel, Italy, Japan, Jordan, Korea, Republic of, Kuwait and more
-
University of Witwatersrand, South AfricaGlaxoSmithKline; University of Oxford; Medical Research Council, South Africa; University...CompletedDiabetes Mellitus, Type 2 | Insulin Resistance | Menopause | HivSouth Africa
-
SanofiCompletedType 2 Diabetes MellitusSouth Africa, United States, Mexico, United Kingdom
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsCompletedCardiovascular Diseases | Diabetes Mellitus, Type 2 | Antiretroviral Therapy, Highly ActiveSouth Africa
-
SanofiCompletedType 2 Diabetes MellitusFrance, Poland, Germany, Italy, Netherlands, Belgium, Denmark, Chile, South Africa, Australia, Argentina
-
Abbott ProductsQuintiles, Inc.CompletedType 2 DiabetesBulgaria, Poland, South Africa
-
Eli Lilly and CompanyCompletedType 2 DiabetesIndia, Mexico, New Zealand, South Africa
-
SanofiCompletedType 2 Diabetes MellitusArgentina, Colombia, Egypt, Hong Kong, India, Indonesia, Lebanon, Malaysia, Peru, Philippines, Saudi Arabia, South Africa, Thailand, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSouth Africa, United Arab Emirates, India
-
University of North Carolina, Chapel HillUniversity of Pretoria; SADC Research CentreCompletedHIV Infections | Pregnancy Related | HSV-2 InfectionSouth Africa
-
Harriet Shezi Children's ClinicUnknownChildren With Confirmed HIV Infection | Receiving ART Regimen Containing 2 NRTIs + LPV/RTV at Standard Dose | Successfully Completed TB Treatment in the Past 2 to 6 Weeks of EnrollmentSouth Africa
-
PfizerCompletedGaucher DiseaseIsrael, Paraguay, South Africa
-
Shabir MadhiRecruitingCOVID-19 | SARS-CoV2 InfectionSouth Africa
-
SanofiCompletedType 2 Diabetes MellitusMexico, South Africa, United States, Mauritius, Spain, Turkey
-
PfizerCompletedGaucher DiseaseIsrael, South Africa, Paraguay
-
University of JohannesburgCompletedChronic Tension-type HeadachesSouth Africa
-
Vaccine Company, Inc.Active, not recruitingSARS-CoV-2 | SARS-CoVSouth Africa
-
Desmond Tutu HIV FoundationAmsterdam Institute for Global Health and Development; University of Cape Town and other collaboratorsCompletedCovid19 | Sars-CoV-2 InfectionSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Croatia, Poland, Romania, South Africa, Turkey
-
University of AdelaideSalk Institute for Biological Studies; University of South AustraliaCompletedObesity | Type2 DiabetesAustralia
-
Nova Laboratories LimitedCompletedAcute Lymphoblastic LeukemiaSouth Africa
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusCanada, Romania, South Africa
-
SanofiCompletedType 2 Diabetes MellitusFrance, Russian Federation, United States, Argentina, Canada, Germany, South Africa, Italy, Netherlands, United Kingdom, Australia, Chile
-
University of Cape TownUniversity of KwaZuluUnknownSevere Acute Respiratory Syndrome Coronavirus 2South Africa
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Turkey, Egypt, Philippines, United Arab Emirates, Bangladesh, Colombia, Singapore, South Africa
-
Advanced Imaging Projects, LLCUniversity of Witwatersrand, South Africa; Postgraduate Institute of Medical...Not yet recruitingBreast Cancer Stage IVIndia, South Africa
-
South African National Blood ServiceUnknownTherapeutic Use of Convalescent Plasma in the Treatment of Patients With Moderate to Severe COVID-19COVID-19 | SARS-CoV-2 Infection | Severe Acute Respiratory Syndrome Coronavirus 2South Africa
-
Gritstone bio, Inc.Completed
-
Entos Pharmaceuticals Inc.Canadian Institutes of Health Research (CIHR); Aegis Life, Inc.; Clinical Pharma... and other collaboratorsCompletedSARS-CoV-2Burkina Faso, Canada, Senegal, South Africa
-
AstraZenecaCompletedType 2 DiabetesUnited States, Russian Federation, South Africa, Taiwan
-
University of MiamiTerminated
-
Eli Lilly and CompanyCompletedHealthy | Type 2 Diabetes Mellitus (T2DM)United States, Singapore
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States, Poland, Mexico, Hungary, Spain, Romania, South Africa, Denmark, Czechia, Sweden
-
AIDS Malignancy ConsortiumNational Cancer Institute (NCI); University of Arkansas; The Emmes Company, LLC; University of StellenboschWithdrawnHIV Infection | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | FIGO Stage IIB Cervix Carcinoma | FIGO Stage III Cervix Carcinoma | FIGO Stage IVA Cervix CarcinomaSouth Africa, Zimbabwe
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusUnited States, Romania, Canada, Mexico, South Africa
-
Ionis Pharmaceuticals, Inc.CompletedType 2 Diabetes MellitusUnited States, South Africa